A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer
Yukiharu Todo(National Hospital Organization Hokkaido Medical Center), Noriaki Sakuragi(Hokkaido University), Shinichiro Minobe(National Hospital Organization Hokkaido Medical Center), Hidemichi Watari(Hokkaido University of Science), Kazuhira Okamoto(National Hospital Organization Hokkaido Medical Center), Yosuke Konno(Hokkaido University of Science), Masanori Kaneuchi(Sapporo University), Yoshihiro Suzuki(Hokkaido University), Hidenori Kato(University of Electro-Communications), Mahito Takeda(Sapporo University)
Cited by 20
Related Papers
Apoptosis and Molecular Targeting Therapy in Cancer
|BioMed Research International|2014|1.1k
Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis
|Oncogene|2012|305
Structural insights into the histone H1-nucleosome complex
|Proceedings of the National Academy of Sciences|2013|215
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164